SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/4B633D1C1F5161DD9FA4A460CF2F2F5A5C39175540B343BC9068A91392AAF8014B1A335A0AB66887D1C168C3DEBBC481>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/4B633D1C1F5161DD9FA4A460CF2F2F5A5C39175540B343BC9068A91392AAF8014B1A335A0AB66887D1C168C3DEBBC481
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/4B633D1C1F5161DD9FA4A460CF2F2F5A5C39175540B343BC9068A91392AAF8014B1A335A0AB66887D1C168C3DEBBC481
http://www.w3.org/2000/01/rdf-schema#comment
"Collectively our findings suggest UBE2T serves as a promising prognostic factor for HCC and functions as an oncogene. The newly identified miR-543/UBE2T/p53 axis may represent a new potential therapeutic target for HCC intervention."
xsd:string
http://purl.uniprot.org/uniprot/#_E9FAC56DF76B85E7700FA17EC7F636706378E5DF0BDC4F2D909C5B71C583A8B17C55E28320C33D9992EEC9A7279D9D3E
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/4B633D1C1F5161DD9FA4A460CF2F2F5A5C39175540B343BC9068A91392AAF8014B1A335A0AB66887D1C168C3DEBBC481
http://purl.uniprot.org/uniprot/Q9NPD8
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/4B633D1C1F5161DD9FA4A460CF2F2F5A5C39175540B343BC9068A91392AAF8014B1A335A0AB66887D1C168C3DEBBC481
http://purl.uniprot.org/uniprot/#_Q9NPD8-mappedCitation-28935368
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/4B633D1C1F5161DD9FA4A460CF2F2F5A5C39175540B343BC9068A91392AAF8014B1A335A0AB66887D1C168C3DEBBC481